Type
. Case for diagnosis. Military medicine. 1969;134(8):611 passim.
Type
. Hypergammaglobulinemia, secondary macroglobulinemia and paraproteinemia in leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1969;37(3):280-7.
Type
. Repository drugs. VI. 4'-[N-(Aralkylidene-, -Benzylidene-, and -naphthylidene)sulfanilyl]anilides, 4'-[N-[(Dimethylamino)methylene]sulfanilyl]anilides, and related sulfanilylanilides with prolonged antimalarial and antileprotic action. Journal of medicinal chemistry. 1969;12(4):591-6.
Type
. Repository drugs. V. 4',4'''-[p-phenylenebis(methylidyneimino-p-phenylenesulfonyl)]bisacetanilide (PSBA) and related 4',4'''-[bis(imino-p-phenylenesulfonyl)]bisanilides, a novel class of long-acting antimalarial and antileprotic agents. Journal of medicinal chemistry. 1969;12(3):363-7.
Type
. Changes in serum copper and PPD-oxidase in different diseases. I. Differential observations in certain types of leprosy and kwashiorkor. The Indian journal of medical research. 1969;57(2):228-36.
Type
. Cross reactivities in lepromin. International archives of allergy and applied immunology. 1969;36(5):450-68.
Type
. A study of antibody response in leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1969;37(1):22-7.
Type
. Biology of the mycobacterioses. Statement of questions. Annals of the New York Academy of Sciences. 1968;154(1):3-7.
Type
. Leprosy in the Toronto area. Canadian Medical Association journal [Internet]. 1968;99(4):176-9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924346/pdf/canmedaj01276-0030.pdf
Type
. [Ossification in phthisical eyes induced by lepra]. Nihon ganka kiyo. 1968;19(5):589-90.